What's your argument exactly? Adap just got a genetically modified t cell autologous therapy approved in the US and they are a UK based company. The debate is whether the US approves autologous therapies and they do. You pumpers are incredible. The last I checked nwbo hadn't even applied in the largest paying market but you do you brother.
Market Data 
Markets 
AI
